On November 12th, the 18th Annual Meeting of Urology Robotics (ERUS) and the 13th German Urological Robotics Society Conference (DRUS) were successfully held in Düsseldorf, Germany. Professor Zhang Xu, Director of the Department of Urology and Medicine, General Hospital of the People's Liberation Army of Chinese, and Professor Ma Xin, Director of the Academic Committee, were invited to broadcast live surgery in Beijing, connecting europe, and successfully demonstrated the difficult surgery of urology - robotic inferior vena cava cancer embolectomy and inferior vena cava dissection, and China's original minimally invasive technology once again amazed the world.
Erus-DRUS Conference Live
As the largest and highest level of urological robotics academic conference in Europe, ERUS-DRUS Conference is committed to the exploration and promotion of new technologies in the field of robotic surgery, and every year it invites top experts in the field of urology around the world to conduct high-level robotic surgical technology demonstrations and academic exchanges.
Professor Zhang Xu demonstrates surgery
Kidney cancer with vena cava carcinoma suppositories is known as the "crown jewel" of urology, and is the most risky and difficult surgery in the field of urology. Professor Zhang Xu's case of cancer suppositories in this demonstration is taller than the first hepatic portal, with a diameter of 4cm, and the operation is extremely challenging. Professor Zhang Xu's exquisite surgical techniques compress the original 2-hour live operation time to 1 hour, the intraoperative inferior vena cava is blocked for 13 minutes, the cancer plug is completely removed, and the blood vessel reconstruction is reliable. After in-depth exchanges with Professor Zhang Xu about inferior vena cava occlusion strategies and reconstruction techniques, the commentators at the venue expressed their admiration one after another.
Professor Ma Xin demonstrates surgery
Inferior vena cava dissection is safe and feasible in patients whose partial cancer suppositories violate the vena cava wall. Based on the preliminary clinical practice and basic research, Professor Zhang Xu's team established a preoperative decision-making and risk assessment model for inferior vena cava dissection. In this meeting, Professor Ma Xin focused on the new technology of preoperative assessment of the degree of inferior vena cava obstruction- vascular endoscopic technology, and verified the clinical value of this technology to guide surgical decision-making through wonderful surgical deduction. The venue review experts gave high praise to the application of this technology.
Surgical scene
The ERUS-DRUS conference fully demonstrated the superb medical skills of Professor Zhang Xu and Professor Ma Xin, in the 2-hour live operation time period, the robot inferior vena cava cancer embolectomy and inferior vena cava dissection were continuously performed, and in the same period of time, two consecutive live broadcasts of high-difficulty cancer suppository surgery also successfully wrote the history of the international conference surgery live broadcast, showing the spirit of innovation and excellence of the Urology Department of the PLA General Hospital, and the "Chinese style" swept the whole field, once again conveying the Chinese voice to the world scholars. It highlights the team's international academic influence in the field of cancer suppositories.
Professor Zhang Xu's team was at the scene of the operation
Professor Zhang Xu has long been committed to the promotion of laparoscopy and robotics in the field of urology, and since 2002, he has been invited to participate in the top Urology Conference in Europe and the surgical demonstration of famous university teaching hospitals, and has trained a number of department chairs and discipline leaders for well-known foreign hospitals such as Europe, america and Southeast Asia, making outstanding contributions to Chinese urology technology going abroad and going to the world!